beta

ONS

Oncobiologics Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Oncobiologics Inc is a clinical-stage biopharmaceutical company. It is engaged in identifying, developing, manufacturing and commercializing complex biosimilar therapeutics in the disease areas of immunology and oncology.

Market Cap: 30.4 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.oncobiologics.com

Shares Outstanding: 25.5 Million

Float: 17.5 Million

Dividend: 0.0 (0.0%)

Beta: -0.674909

Sector: Healthcare

Industry: Biotechnology

Ethical Flags

Longest drawdown: 679 trading days

From: 2016-09-06 To: 2018-12-03

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud